Compare ALEMBIC with WYETH - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs WYETH - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

WYETH 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC WYETH ALEMBIC/
WYETH
 
P/E (TTM) x 77.6 27.7 279.9% View Chart
P/BV x 6.7 5.3 125.0% View Chart
Dividend Yield % 0.2 1.3 12.0%  

Financials

 ALEMBIC   WYETH
EQUITY SHARE DATA
    ALEMBIC
Mar-18
WYETH
Mar-13
ALEMBIC/
WYETH
5-Yr Chart
Click to enlarge
High Rs721,044 6.9%   
Low Rs34818 4.1%   
Sales per share (Unadj.) Rs4.7298.6 1.6%  
Earnings per share (Unadj.) Rs6.157.2 10.7%  
Cash flow per share (Unadj.) Rs6.258.4 10.7%  
Dividends per share (Unadj.) Rs0.2017.00 1.2%  
Dividend yield (eoy) %0.41.8 20.7%  
Book value per share (Unadj.) Rs40.7249.5 16.3%  
Shares outstanding (eoy) m267.0322.72 1,175.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.33.1 361.2%   
Avg P/E ratio x8.716.3 53.3%  
P/CF ratio (eoy) x8.515.9 53.2%  
Price / Book Value ratio x1.33.7 34.9%  
Dividend payout %3.329.7 11.0%   
Avg Mkt Cap Rs m14,13921,157 66.8%   
No. of employees `000NA0.5 0.0%   
Total wages/salary Rs m207400 51.9%   
Avg. sales/employee Rs ThNM13,787.4-  
Avg. wages/employee Rs ThNM813.0-  
Avg. net profit/employee Rs ThNM2,643.3-  
INCOME DATA
Net Sales Rs m1,2556,783 18.5%  
Other income Rs m370353 105.0%   
Total revenues Rs m1,6257,136 22.8%   
Gross profit Rs m1111,617 6.9%  
Depreciation Rs m3827 142.1%   
Interest Rs m26 30.9%   
Profit before tax Rs m4421,938 22.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m24632 3.8%   
Profit after tax Rs m1,6301,301 125.3%  
Gross profit margin %8.923.8 37.1%  
Effective tax rate %5.432.6 16.6%   
Net profit margin %129.819.2 677.3%  
BALANCE SHEET DATA
Current assets Rs m1,8676,984 26.7%   
Current liabilities Rs m5912,056 28.8%   
Net working cap to sales %101.672.6 139.9%  
Current ratio x3.23.4 93.0%  
Inventory Days Days9499 95.0%  
Debtors Days Days7424 307.2%  
Net fixed assets Rs m1,791244 733.1%   
Share capital Rs m534227 235.1%   
"Free" reserves Rs m10,3245,441 189.7%   
Net worth Rs m10,8585,668 191.6%   
Long term debt Rs m4125 164.8%   
Total assets Rs m11,5917,901 146.7%  
Interest coverage x260.9353.3 73.8%   
Debt to equity ratio x00 86.0%  
Sales to assets ratio x0.10.9 12.6%   
Return on assets %14.116.5 85.2%  
Return on equity %15.022.9 65.4%  
Return on capital %15.234.0 44.6%  
Exports to sales %1.50.2 708.4%   
Imports to sales %21.036.3 57.7%   
Exports (fob) Rs m1915 131.1%   
Imports (cif) Rs m2632,465 10.7%   
Fx inflow Rs m1915 127.6%   
Fx outflow Rs m2642,677 9.9%   
Net fx Rs m-244-2,662 9.2%   
CASH FLOW
From Operations Rs m236923 25.5%  
From Investments Rs m-224317 -70.7%  
From Financial Activity Rs m-27-481 5.5%  
Net Cashflow Rs m-15759 -1.9%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 0.2 11.3 1.8%  
FIIs % 9.7 7.2 134.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 30.4 85.9%  
Shareholders   54,701 21,978 248.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   DIVIS LABORATORIES  WOCKHARDT  SUN PHARMA  FRESENIUS KABI ONCO.  FDC  

Compare ALEMBIC With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


May 7, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS